GSDDevonian Health Group Inc.
12.00CAD+18.81%Mkt Cap: 24.30M $P/E:

Devonian Health Group Inc. operates as a clinical stage biopharmaceutical corporation with novel therapeutic approaches targeting unmet medical needs in Canada and Internationally. It engages in the development of botani…

Key Statistics

Company
Market Cap24.30M $
Enterprise Value23.88M $
Revenue (TTM)2.18M $
Gross Profit6.23M $
Net Income (TTM)-4.38M $
Revenue/Share0.8076 USD
Last Price12.00 CAD
Fiscal Year EndJul 2025
MR QuarterApr 2026
Employees8
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)
PEG
EV/EBITDA-5.54
EV/Revenue10.95
P/S11.14
P/B4.78
EPS (TTM)-2.25
EPS (Forward)
52W Range
0.190080% of range15.00
52W High15.00 CAD
52W Low0.1900 CAD
Profitability
Gross Margin36.28%
Oper. Margin-1096.23%
EBITDA Margin-197.67%
Profit Margin-25.49%
ROE-65.80%
ROA-37.98%
Growth
Revenue Growth-97.60%
Earnings Growth
Cash Flow & Leverage
Operating CF-908.71K $
CapEx (TTM)12.64K $
FCF Margin-319.51%
FCF Yield-28.68%
Net Debt-421.95K $
Net Debt/EBITDA0.10
Balance Sheet
Debt/Equity0.01
Current Ratio1.00
Quick Ratio0.78
Book Value/Sh2.509 CAD
Cash/Share0.2590 CAD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 CAD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay DateMay 19, 2017
Splits
Last Split1:60
Split DateJan 22, 2026
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.2.78M
Float2.11M
Insiders12.04%
Institutions0.00%
Short Interest
Short Ratio0.7d
Short % Out.0.03%
Shares Short107
Short (prev mo.)57
Technical
SMA 508.829 (+35.9%)
SMA 20010.90 (+10.1%)
Beta1.28
S&P 52W Chg18.16%
Avg Vol (30d)1.41K
Avg Vol (10d)1.50K
Technical Indicators
RSI (14)64.1
MACD0.1392
MACD Signal-0.1888
MACD Hist.+0.3280
BB Upper11.17 CAD
BB Middle8.658 CAD
BB Lower6.141 CAD
BB Width58.14%
ATR (14)0.9223 CAD
Vol Ratio (20d)6.33x